159 related articles for article (PubMed ID: 37056711)
1. Pediatric diffuse hemispheric glioma H3 G34-mutant with gains of the BRAF locus: An illustrative case.
Marlow C; Cuoco JA; Hoggarth AR; Stump MS; Apfel LS; Rogers CM
Rare Tumors; 2023; 15():20363613231168704. PubMed ID: 37056711
[TBL] [Abstract][Full Text] [Related]
2. Imaging features associated with H3 K27-altered and H3 G34-mutant gliomas: a narrative systematic review.
Lasocki A; Abdalla G; Chow G; Thust SC
Cancer Imaging; 2022 Nov; 22(1):63. PubMed ID: 36397143
[TBL] [Abstract][Full Text] [Related]
3. High frequency of PDGFRA and MUC family gene mutations in diffuse hemispheric glioma, H3 G34-mutant: a glimmer of hope?
Hu W; Duan H; Zhong S; Zeng J; Mou Y
J Transl Med; 2022 Feb; 20(1):64. PubMed ID: 35109850
[TBL] [Abstract][Full Text] [Related]
4. Epigenetics to clinicopathological features: a bibliometric analysis of H3 G34-mutant diffuse hemispheric glioma literature.
Roach JT; Riviere-Cazaux C; Wells BA; Boop FA; Daniels DJ
Childs Nerv Syst; 2024 Apr; ():. PubMed ID: 38613587
[TBL] [Abstract][Full Text] [Related]
5. H3 G34-mutant high-grade glioma.
Lim KY; Won JK; Park CK; Kim SK; Choi SH; Kim T; Yun H; Park SH
Brain Tumor Pathol; 2021 Jan; 38(1):4-13. PubMed ID: 32995948
[TBL] [Abstract][Full Text] [Related]
6. Case Report: Evolutionary Clinical-Radiological Features of a Diffuse Hemispheric Glioma, H3 G34 Mutant with Over 5 Years of Survival.
Yamada CAF; Soldatelli MD; do Amaral LLF; Campos CMS; de Moraes PL; Chaddad-Neto FEA; Lancellotti CLP
Case Rep Oncol; 2023; 16(1):279-286. PubMed ID: 37123609
[TBL] [Abstract][Full Text] [Related]
7. [Pediatric-Type Diffuse High-Grade Gliomas].
Natsumeda M
No Shinkei Geka; 2023 Sep; 51(5):876-883. PubMed ID: 37743339
[TBL] [Abstract][Full Text] [Related]
8. Midline invasion predicts poor prognosis in diffuse hemispheric glioma, H3 G34-mutant: an individual participant data review.
Kegoya Y; Otani Y; Inoue Y; Mizuta R; Higaki F; Washio K; Koizumi S; Kurozumi K; Ishida J; Fujii K; Yamamoto N; Tanaka Y; Date I
J Neurooncol; 2024 Mar; 167(1):201-210. PubMed ID: 38427132
[TBL] [Abstract][Full Text] [Related]
9. Systematic review of diffuse hemispheric glioma, H3 G34-mutant: Outcomes and associated clinical factors.
Crowell C; Mata-Mbemba D; Bennett J; Matheson K; Mackley M; Perreault S; Erker C
Neurooncol Adv; 2022; 4(1):vdac133. PubMed ID: 36105387
[TBL] [Abstract][Full Text] [Related]
10. H3 G34-mutant high-grade gliomas: integrated clinical, imaging and pathological characterisation of a single-centre case series.
Lavrador JP; Reisz Z; Sibtain N; Rajwani K; Baig Mirza A; Vergani F; Gullan R; Bhangoo R; Ashkan K; Bleil C; Zebian B; Clark B; Laxton R; King A; Bodi I; Al-Saraj S
Acta Neurochir (Wien); 2023 Jun; 165(6):1615-1633. PubMed ID: 36929449
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of diffuse hemispheric gliomas, H3 G34-mutant in adults.
Picart T; Barritault M; Poncet D; Berner LP; Izquierdo C; Tabouret E; Figarella-Branger D; Idbaïh A; Bielle F; Bourg V; Vandenbos FB; Moyal EC; Uro-Coste E; Guyotat J; Honnorat J; Gabut M; Meyronet D; Ducray F
Neurooncol Adv; 2021; 3(1):vdab061. PubMed ID: 34056608
[TBL] [Abstract][Full Text] [Related]
12. Diffuse hemispheric glioma with H3-3B G34R mutation: Expanding the spectrum of histone H3 genes in diffuse hemispheric glioma, H3 G34-mutant.
Nazem A; Lavezo J; Abdullaev Z; Aldape K; Quezado M; Cimino PJ; Pratt DW; Jenkins RB; Ida CM
J Neuropathol Exp Neurol; 2023 Dec; 83(1):58-60. PubMed ID: 37878797
[No Abstract] [Full Text] [Related]
13. Paediatric-type diffuse high-grade gliomas in the 5th CNS WHO Classification.
Gianno F; Giovannoni I; Cafferata B; Diomedi-Camassei F; Minasi S; Barresi S; Buttarelli FR; Alesi V; Cardoni A; Antonelli M; Puggioni C; Colafati GS; Carai A; Vinci M; Mastronuzzi A; Miele E; Alaggio R; Giangaspero F; Rossi S
Pathologica; 2022 Dec; 114(6):422-435. PubMed ID: 36534421
[TBL] [Abstract][Full Text] [Related]
14. Utility of arterial spin labeling for objective assessment of intratumoral microvessels in diffuse hemispheric glioma, H3 G34R-mutant: A case report and literature review.
Kitakami K; Beppu T; Sato Y; Kurose A; Ogasawara K
Radiol Case Rep; 2023 Mar; 18(3):856-861. PubMed ID: 36589502
[TBL] [Abstract][Full Text] [Related]
15. Radiological and Immunostaining Characteristics of H3.3 G34R-Mutant Glioma: A Report of 3 Cases and Review of the Literature.
Onishi S; Amatya VJ; Karlowee V; Takeshima Y; Sugiyama K; Kurisu K; Yamasaki F
Pediatr Neurosurg; 2020; 55(5):319-325. PubMed ID: 33227796
[TBL] [Abstract][Full Text] [Related]
16. Leptomeningeal disease in histone-mutant gliomas.
Diaz M; Rana S; Silva Correia CE; Reiner AS; Lin AL; Miller AM; Graham MS; Chudsky S; Bale TA; Rosenblum M; Karajannis MA; Pentsova E
Neurooncol Adv; 2023; 5(1):vdad068. PubMed ID: 37346983
[TBL] [Abstract][Full Text] [Related]
17. Histologically distinct neuroepithelial tumors with histone 3 G34 mutation are molecularly similar and comprise a single nosologic entity.
Korshunov A; Capper D; Reuss D; Schrimpf D; Ryzhova M; Hovestadt V; Sturm D; Meyer J; Jones C; Zheludkova O; Kumirova E; Golanov A; Kool M; Schüller U; Mittelbronn M; Hasselblatt M; Schittenhelm J; Reifenberger G; Herold-Mende C; Lichter P; von Deimling A; Pfister SM; Jones DT
Acta Neuropathol; 2016 Jan; 131(1):137-46. PubMed ID: 26482474
[TBL] [Abstract][Full Text] [Related]
18. Cerebral hemispheric glioblastoma with PNET-like morphology and histone H3.3 G34 mutation in younger patients: Report of three rare cases and diagnostic pitfalls.
Cheng Y; Bao W; Wu Q
Indian J Pathol Microbiol; 2020; 63(2):262-266. PubMed ID: 32317528
[TBL] [Abstract][Full Text] [Related]
19. Characterization of Diffuse Gliomas With Histone H3-G34 Mutation by MRI and Dynamic 18F-FET PET.
Vettermann FJ; Felsberg J; Reifenberger G; Hasselblatt M; Forbrig R; Berding G; la Fougère C; Galldiks N; Schittenhelm J; Weis J; Albert NL; Schüller U
Clin Nucl Med; 2018 Dec; 43(12):895-898. PubMed ID: 30358620
[TBL] [Abstract][Full Text] [Related]
20. Neuroimaging features of diffuse hemispheric glioma, H3 G34-mutant: A case series and systematic review.
Kurokawa R; Baba A; Kurokawa M; Pinarbasi ES; Makise N; Ota Y; Kim J; Srinivasan A; Moritani T
J Neuroimaging; 2022 Jan; 32(1):17-27. PubMed ID: 34632671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
